DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
12.35
-0.16 (-1.28%)
At close: Sep 18, 2026, 4:00 PM EDT
12.37
+0.02 (0.16%)
After-hours: Sep 18, 2026, 4:10 PM EDT
DBV Technologies Revenue
DBV Technologies had revenue of $700.00K in the quarter ending June 30, 2026, a decrease of -53.33%. This brings the company's revenue in the last twelve months to $5.02M, up 29.26% year-over-year. In the year 2025, DBV Technologies had annual revenue of $5.64M with 35.77% growth.
Revenue (ttm)
$5.02M
Revenue Growth
+29.26%
P/S Ratio
144.88
Revenue / Employee
$29,624
Employees
170
Market Cap
729.61M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.64M | 1.49M | 35.77% |
| Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
| Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
| Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
| Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
| Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
| Dec 31, 2019 | 14.71M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pharming Group | 366.48M |
| Zevra Therapeutics | 136.07M |
| Gyre Therapeutics | 109.82M |
| 4D Molecular Therapeutics | 92.01M |
| Crescent Biopharma | 11.88M |
| Aclaris Therapeutics | 8.22M |
| Silence Therapeutics | 615.00K |
DBVT News
- 4 days ago - DBV Technologies Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 11 days ago - DBV Technologies Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 16 days ago - DBV Technologies S.A.: DBV Technologies to Participate in Upcoming September Investor Conferences - Finanz Nachrichten
- 16 days ago - DBV Technologies to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 17 days ago - DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 - Finanz Nachrichten
- 17 days ago - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026 - GlobeNewsWire
- 7 weeks ago - DBVT Plans $50M ADS Share Issuance Amid Unprofitable Growth Phase - GuruFocus
- 7 weeks ago - DBV Technologies S.A.: DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq - Finanz Nachrichten